Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Narrative)

v3.23.1
Commitments and Contingencies (Details Narrative)
 12 Months Ended
Dec. 31, 2022
USD ($)
Onxeo S.A  
Option And License Agreement Description the option agreement includes clinical, regulatory, developmental and sales milestones that could reach up to $108 million if the Company achieves all milestones, and escalating royalties on net sales from 5% to 10%
XOMA Ltd  
Option And License Agreement Description regulatory and sales milestones for MNPR-101 that could reach up to $14.925 million if the Company achieves all milestones
GEIS  
Clinical-related Expenses $ 300,000
1,202 square feet [Member]  
Operating Lease Monthly Payment 2,379
Additional Office Space [Member]  
Operating Lease Monthly Payment 1,859
Level 1  
Operating Lease Monthly Payment $ 4,238